Alexey A. Tryakin
Doct. Sci. (Medicine), Head of the Chemotherapy Department, Department of Antitumor Drug Therapy №2, N.N. Blokhin National Medical Research Center of Oncology, ORCID: https://orcid.org/0000-0003-2245-214X
Статьи автора:
PATHWAY DIRECTED MECHANISMS OF ANTI-EGFR RESISTANCE IN COLORECTAL CANCER (REVIEW)
Background: Targeting the epidermal growth factor receptor (EGFR) with cetuximab or panitumumab (anti-EGFR MAb) has been historically reserved ...
